Related Experiment Video
Updated: Jul 7, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic
Rinku Yadav1, Rosy Bala1, Aparna Parmar2
1Microbiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University) Mullana, Ambala, IND.
None:
Background Pulmonary tuberculosis (TB) continues to be a major public health problem, especially with the rising number of drug-resistant TB cases. Rapid molecular tests such as cartridge-based nucleic acid amplification test (CB-NAAT) and line probe assay (LPA) help in the early diagnosis of TB and detection of drug resistance, allowing timely treatment and better disease control. Methods This cross-sectional study included 3451 pulmonary samples collected from patients suspected of having pulmonary tuberculosis. All samples were tested by CB-NAAT for detection of Mycobacterium tuberculosis and rifampicin resistance. Samples showing drug resistance were further analyzed by first-line LPA to identify genetic mutations associated with rifampicin and isoniazid resistance. Results Among the 3451 pulmonary samples tested, M. tuberculosis was detected in 758 (21.9%) cases, while in 2682 (77.7%) samples, it was not detected. Invalid/error results were observed in only 11 (0.3%) samples. Rifampicin resistance was identified in 42 (5.5%) isolates. Sputum was the most common positive sample, accounting for 661 (87.2%) cases. Most patients were newly diagnosed TB cases (n=662, 87.3%), whereas previously treated cases, TB contacts, and HIV-positive patients constituted a smaller proportion. First-line LPA detected multidrug-resistant tuberculosis (MDR-TB) in 29 isolates. The most common mutation associated with rifampicin resistance was rpoB MUT3 (S531L/H531L), while katG MUT1 (S315T1) was the predominant mutation linked to isoniazid resistance. Conclusion CB-NAAT and LPA proved to be useful and reliable methods for rapid diagnosis of pulmonary tuberculosis and detection of drug resistance. Early identification of drug-resistant TB through molecular techniques can help in timely treatment initiation and improved tuberculosis control. The predominance of rpoB S531L/H531L and katG S315T1 mutations suggests their important role in the development of anti-tubercular drug resistance.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
